|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/30 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2654789 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11801741.7 |
| Europos patento paraiškos padavimo data | 2011-12-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/073659 |
| Data | 2011-12-21 |
| (87) | Numeris | WO 2012/085132 |
| Data | 2012-06-28 |
| (30) | Numeris | Data | Šalis |
| 201061426041 P | 2010-12-22 | US |
| (72) |
BENSUSSAN, Armand, FR
BONNEFOY-BERARD, Nathalie, FR
ELIAOU, Jean-Franēois, FR
ALBERICI, Gilles, FR
BASTID, Jeremy, FR
|
| (73) |
INSERM - Institut National de la Santé et de la Recherche Médicale,
101, rue de Tolbiac, 75013 Paris,
FR
Orega Biotech, 15 Chemin du Saquin L`Espace Européen - Bātiment G, 69130 Ecully, FR |
| (54) | ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF |
| ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF |